Suppr超能文献

乳腺浸润性癌针芯活检标本雌激素受体表达评估的可靠性

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

作者信息

Hodi Zsolt, Chakrabarti Jayeta, Lee Andrew H S, Ronan John E, Elston Christopher W, Cheung Kwok Leung, Robertson John F R, Ellis Ian O

机构信息

Departments of Histopathology and Surgery, Nottingham City Hospital, UK.

出版信息

J Clin Pathol. 2007 Mar;60(3):299-302. doi: 10.1136/jcp.2006.036665. Epub 2006 May 26.

Abstract

AIM

To assess the reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. Previous studies have mostly been small, with a range of agreement from 62% to 100%.

METHODS

Retrospective audit of 338 tumours surgically excised within 60 days of core biopsy, that had had oestrogen receptor assessed on both the core biopsy and tumour specimens. Surgical specimens were incised when fresh to ensure good fixation. External controls including a weakly positive tumour were included in each immunohistochemistry run.

RESULTS

Oestrogen receptor expression was bimodal, with H score in both specimens of either 0 or >50 in 96% of tumours. Using H score cut-off of 10 for positivity, there was an agreement between core and excision in 334 of 338 tumours (98.8%). All discrepancies were between weakly positive and negative tumours. Intratumoral heterogeneity could explain the one tumour that was negative on core and positive on excision. H score tended to be slightly higher on core than excision (means 146 and 136). Better fixation on the core is the most likely explanation for this and for the three tumours that were positive on core and negative on excision. Repeat staining on tumours with discrepant results gave similar results in all except one case. An internal control was present in 97% of excisions and 55% of cores of oestrogen receptor-negative tumours; the internal control stained positively in all except two sections.

CONCLUSION

Oestrogen receptor can be assessed reliably on needle core biopsies of invasive carcinomas of the breast.

摘要

目的

评估乳腺浸润性癌针芯活检标本中雌激素受体表达评估的可靠性。以往的研究大多规模较小,一致性范围在62%至100%之间。

方法

对在针芯活检后60天内手术切除的338个肿瘤进行回顾性审计,这些肿瘤在针芯活检和肿瘤标本上均进行了雌激素受体评估。手术标本在新鲜时切开以确保良好固定。每次免疫组织化学检测均纳入包括弱阳性肿瘤在内的外部对照。

结果

雌激素受体表达呈双峰分布,96%的肿瘤在两个标本中的H评分要么为0,要么>50。采用H评分截断值10作为阳性标准,338个肿瘤中有334个(98.8%)在针芯活检和切除标本之间结果一致。所有差异均存在于弱阳性和阴性肿瘤之间。肿瘤内异质性可以解释1个针芯活检为阴性而切除标本为阳性的肿瘤。针芯活检的H评分往往略高于切除标本(均值分别为146和136)。最可能的解释是针芯活检的固定更好,以及3个针芯活检为阳性而切除标本为阴性的肿瘤。对结果不一致的肿瘤进行重复染色,除1例之外所有结果均相似。雌激素受体阴性肿瘤的切除标本中有97%以及针芯活检标本中有55%存在内部对照;除2个切片外,内部对照均呈阳性染色。

结论

乳腺浸润性癌针芯活检可可靠地评估雌激素受体。

相似文献

2
Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast.
Histopathology. 2012 May;60(6):880-4. doi: 10.1111/j.1365-2559.2011.04144.x. Epub 2012 Feb 9.
5
7
Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
Cytopathology. 2012 Jun;23(3):181-6. doi: 10.1111/j.1365-2303.2011.00853.x. Epub 2011 Mar 6.

引用本文的文献

1
Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma.
Virchows Arch. 2023 Aug;483(2):215-224. doi: 10.1007/s00428-023-03563-0. Epub 2023 May 24.
4
BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score.
BMC Clin Pathol. 2018 Dec 18;18:14. doi: 10.1186/s12907-018-0082-3. eCollection 2018.
5
Improving accuracy of breast cancer biomarker testing in India.
Indian J Med Res. 2017 Oct;146(4):449-458. doi: 10.4103/ijmr.IJMR_896_16.
7
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Breast Cancer Res. 2016 Jun 28;18(1):68. doi: 10.1186/s13058-016-0725-1.
8
Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.
Cell Oncol (Dordr). 2015 Feb;38(1):39-48. doi: 10.1007/s13402-014-0192-6. Epub 2014 Sep 4.
9
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.
PLoS One. 2014 Jun 30;9(6):e100488. doi: 10.1371/journal.pone.0100488. eCollection 2014.
10
Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.
J Clin Oncol. 2012 Feb 20;30(6):587-92. doi: 10.1200/JCO.2010.33.5232. Epub 2011 Nov 28.

本文引用的文献

6
Biopathologic profile of breast cancer core biopsy: is it always a valid method?
Cancer Lett. 2005 Jan 31;218(1):117-21. doi: 10.1016/j.canlet.2004.07.041.
7
Core biopsy is accurate in determining the hormone receptor status of early breast cancer.
Am J Surg. 2004 Apr;187(4):568; author reply 568. doi: 10.1016/j.amjsurg.2003.02.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验